Just a moment, the page is loading...
PSR

ViiV Healthcare ISS and Collaborative Studies


Scope:

  • Interventional clinical studies (phase I-IV), including Implementation Science Projects (ISP)
  • Non-interventional studies (e.g., observational studies including epidemiology, meta-analyses and pooled analyses of data from previously conducted interventional studies, methodology development, mathematical and health economic models and certain health outcomes studies).
  • In vitro or animal studies that include funding and/or collaboration.**
Registration: To fully utilize this site, you must first register a profile. Once registered, you will be able to:
  • Submit a full study proposal on the provided template into VH's ISS or SCS system for review. The appropriate proposal form can be found here.
  • Submit all required documents.
  • Check the status of both proposals and previously approved studies.
  • Make updates to ongoing studies supported by ViiV.
  • Post and receive electronic documentation directly through the system.
  • Receive periodic prompts regarding key milestones and deliverables (conference presentations and publications) associated with your proposals or previously approved studies.
Decision Timeline: Timelines for decisions on proposals can be viewed in the program guidance section and are determined upon receipt of all required documents in this portal.
  • Full ViiV ISS/SCS Proposal Form
  • CV or biosketch
  • ViiV Budget Tool (if requesting funding)

**Pure Substance requests that do not require funding should be submitted directly from the Pure Substance Requestoverview page .

This information to be updated with new text…. This information to be updated with new text…. This information to be updated with new text…. This information to be updated with new text…. This information to be updated with new text…. This information to be updated with new text…. This information to be updated with new text….

Note: For active RFP “Areas of Interest” please scroll to the bottom of this page.

Types of research eligible for support:

  • Interventional clinical studies (phase I-IV).
  • Non-interventional studies and studies using biological samples or data from previous studies (e.g. meta-analyses and pooled analyses, observational studies including epidemiology, methodology development and health outcomes studies).
  • Mathematical and health economic models.
  • Implementation Sciences Project (ISP). (See Implementation Science Proposal Guidance for additional information.)
  • In vitro or animal studies that include funding.**

In order to fully utilize this site, you must first register a profile. Once registered, you will be able to:

  • Submit a study high level "Concept" directly into VH's ISS system, which will allow ViiV to determine if they are interested in this proposal and would like to have a full proposal submission.
  • Submit full study proposals directly into VH's ISS system, which will facilitate more timely reviews and decisions. Note: For proposals involving Implementation Science please review the Implementation Science Proposal Guidance in the toolbox before submitting the proposal.
  • Check on the status of both proposals and previously approved studies.
  • Post and receive electronic documentation directly through the system.
  • Receive periodic prompts regarding key milestones and deliverables associated with your proposals or previously approved studies.
*ISS expertise is limited to benefit/risk expertise related to the VH product in the study.
**Pure Substance requests that do not require funding should be submitted directly from the Pure Substance Request overview page.
Return to Home
All Safety Reporting must be conducted as per your study agreement. If you need to report a suspected side effect for a ViiV Healthcare medicine that is not part of your study, please click the following.

Report a side effect

To report a suspected side effect, please use the online reporting form below. This facility is provided under our service agreement with GlaxoSmithKline (GSK), so please choose 'ViiV Healthcare medicines' from the drop-down product list on the form. In North America, you can report a side effect via the GSK Response Center at 1-888-825-5249, Monday-Friday, 8am - 8pm ET.

VH recommends that all proposal submissions are discussed with a VH Representative BEFORE being submitted to this portal

- Back to Top -
© 2025 ViiV Healthcare
Trademarks are owned by or licensed to the ViiV Healthcare group of companies